Dr Reddy’s Laboratories on Thursday said all claims against it in the antitrust litigation filed in the US, related to a prescription medicine Revlimid, used in treatment of multiple myeloma have been dismissed.
Copyright © 2024 | WordPress Theme by MH Themes